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While sociologists have made significant theoretical contributions to the antimicrobial
resistance (AMR) debate, little attention has been given to the antimicrobial products
themselves. Here we advocate a significant new direction which centers on the social and
material life of antimicrobials, specifically on what they are made from and how this affects
their use. This focus is timely because, in the context of declining efficacy of biomedical
antibiotics, diverse materials are increasingly taking center stage in research and drug
discovery as potential agents for new antimicrobial treatments. Of particular significance
are natural antimicrobials, such as plants, honey and clay, whose antimicrobial potential
is well-documented and which are increasingly moving into mainstream antimicrobial
research. Alongside this biomedical focus, we suggest that the social and material lives
of these antimicrobial materials require attention to (i) highlight the ways they have been,
and continue to be, used in diverse cultures globally, (ii) explore ways we might theorize
these materials within wider AMR debates, and (iii) examine the impact of antimicrobials’
materiality on their use by patients. This article takes the example of clay, whose
antimicrobial properties are well-established and which has been used to treat wounds
and gastrointestinal problems for millennia. We first locate clay as an exemplar of a wider
shift toward natural products drug discovery in pharmaceutical science and antimicrobial
research. We then offer a number of theoretical “ways in” for sociologists to begin making
sense of clay as it comes under the western biomedical gaze. We map these conceptual
lenses on to clay’s physical and symbolic mobility from its use in the global south
into western biomedical research and commercialization. We particularly concentrate
on post-colonial theory as a means to understand clay’s movement from global south
to north; laboratory studies to examine its symbolic transformation to a black-boxed
antimicrobial artifact; and valuation practices as a lens to capture its movement from the
margins to the mainstream. We finish by reflecting on the importance of materiality in
addressing optimal use of medicines and by advocating an interdisciplinary approach to
AMR which positions sociology as a key contributor to AMR solutions.
Keywords: clay, materiality, optimization, social life, geophagy, value, laboratory life, post-colonial theory
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INTRODUCTION
This paper argues for a significant new direction in sociological
approaches to antimicrobial resistance (AMR) which focuses on
the materiality of antimicrobial artifacts. While social scientists
have made significant theoretical contributions to understanding
AMR, as well as its framing and responses to it [see Macintyre
(2014), Wood (2016), and Will (2018) for overviews], limited
attention has been given to antimicrobial products themselves
and how their materiality (i.e., what they are made from, what
they look like, how they are produced) may influence their
use. This is despite a recent “materiality turn” in the social
sciences (see Pinch and Swedberg, 2008) and the well-established
tradition, particularly in science and technology studies (STS),
of centralizing non-human artifacts; Bruno Latour, after all,
reminds us to “follow the actors” (Latour, 2005, p. 237).
Such a focus on antimicrobials’ materiality is important
because, in the context of the declining efficacy of existing
antimicrobial medicines, diverse materials are beginning to take
center stage in research and drug discovery as potential agents
for new treatments (Newman, 2019). Of particular significance
are natural products such as honey, plants, and clay whose
antimicrobial potential is well-known and are therefore prime
candidates for new antimicrobial drug discovery programmes
(see McLoone et al., 2016 for a review of honey). The application
of computational biological approaches and modern high
throughput screening techniques to uncover nature’s “treasure
trove” Davies (2011, p. 5) opens up the potential for a fresh
generation of antimicrobials derived from natural products
(Thomford et al., 2018). Alongside this biomedical focus on
diverse materials, we suggest that sociologists are best placed
to make sense of the social and material lives of these natural
antimicrobials, particularly to locate their materiality within
discussions of optimizing their use.
In this article we take the example of clay, whose antimicrobial
properties are well-documented and which has been used for
centuries to treat wound infections and gastrointestinal problems
(e.g.,Williams andHaydel, 2010;Williams, 2019). As an exemplar
of the accession of natural products into western antimicrobial
research, we suggest that clay provides a fruitful lens to explore
the shifting material life of antimicrobials. We offer a number
of theoretical “ways in” to this exploration, which we map
onto the physical and symbolic mobility of clay from its use in
the global south into western biomedical research. These “ways
in” are not intended to be comprehensive; we offer only brief
overviews of each theoretical approach and pose questions and
suggestions, rather than answers, as to how they may be useful
in understanding natural product drug discovery approaches
to antimicrobials. We also deliberately avoid over-synthesizing
these “ways in” as we do not wish to present an instructional
schema for researchers approaching clay sociologically. The
intention, then, is to set an agenda for a novel approach to AMR
which centers on antimicrobial products and to demonstrate its
theoretical feasibility.
First, we offer an overview of the shift toward natural
antimicrobials before we hone in on clay and examine the ways
that social scientists have previously made sense of medicinal
applications of clay, primarily through its ingestion. We then
suggest a number of theoretical “ways in” for sociologists
to begin thinking specifically about the place of clay in the
antimicrobial landscape, but more widely about the materiality
of diverse antimicrobial products and what this might mean for
their use by practitioners and patients. We then consider what
insights can be learned for optimizing antibiotic use through this
focus on materiality. Finally, we argue for an interdisciplinary
approach to AMR in which sociologists collaborate not just with
our closest disciplinary neighbors, but across the natural and
physical sciences boundaries in order to position sociology as an
important contributor to AMR policy and practice solutions (see
Will, 2018).
ANTIMICORBIAL RESISTANCE AND THE
SHIFT TOWARD NATURAL PRODUCTS
DRUG DISCOVERY
Antimicrobial Resistance
AMR refers to changes in pathogenic (that is disease-causing)
microorganisms (viruses, bacteria, fungi, or protozoa) that
allow them to acquire resistance to existing medication or
treatment regimes. Promoted by inappropriate and excessive use
of antimicrobials in human and veterinary medicine, AMR poses
a significant global public health problem as common infections
become increasingly challenging to treat and previously routine
surgical procedures become potentially hazardous (WorldHealth
Organization, 2014). Coupled with this, few new antimicrobial
drugs have been discovered or developed in recent years while
history has demonstrated that further evolution of resistance is
inevitable (Rodríguez-Rojas et al., 2013). This has created an
“antimicrobial perfect storm” (Broom et al., 2014, p. 81) which
the United Nations (2019, p. 1) suggests will have a “disastrous
impact within a generation.” In the UK, a recent government
report predicted that AMR is likely to overtake cancer as the
leading cause of death over the next 30 years (O’Neill, 2016),
while the World Health Organization (2014, p. 19) estimated
that the current $21–34 billion/year cost of AMR to the US
health system will escalate as drug resistance increases. de Sosa
et al. (2010) note that the impact of AMR is likely to be more
extreme in developing countries where a higher infectious disease
burden and precarious financial circumstances prevent the rapid
development and deployment of new treatment agents.
Natural Products Drug Discovery
In the context of the declining efficacy of existing antimicrobials,
biomedical researchers are turning to increasingly innovative
methods, approaches and materials to identify new agents.
A key aspect of this is “natural products drug discovery”
where researchers look to natural materials for their therapeutic
potential; in other words, science “revert[s] to ‘nature’ for
answers” (Thomford et al., 2018, p. 1). While this movement
toward natural products represents a shift in contemporary
drug discovery practice, the natural world is not uncharted
territory for pharmaceutical research and drug discovery
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(Mandal et al., 2018). Rather, a significant number of well-
established biomedical therapies are derived from natural
products, including quinine (antimalarial from the bark of
the Cinchona tree), codeine (painkiller from poppies), and
Taxol (cancer therapy from the Pacific yew tree). Indeed,
natural products drug discovery as an approach within the
pharmaceutical industry had a “golden age” in the 1950s and
1960s during which time the US Department of Agriculture
undertook a specific programme of plant extract collection and
screening (Cragg and Newman, 2015) and a significant number
of naturally-derived pharmaceutical products were brought to
market (Shen, 2015, p. 1297). This heyday of natural product
drug discovery was tied up with what has been called the “golden
age of antibiotics” during the middle decades of the twentieth
century when the discovery of new antibiotics coincided, in the
UK, with improvements in social housing and the introduction
of the National Health Service. In this new healthcare and
public healthmilieu, antibiotics were positioned as wonder-drugs
heralding the end of infectious disease (see Burnett, 1953). It
should be noted that themajority of antibiotics discovered during
this period, and subsequently, originated as natural products
(Newman, 2019).
In the latter half of the twentieth century, however, many
pharmaceutical companies scaled back their focus on natural
products as high throughput screening and novel synthesis
methods enabled the creation of large libraries of synthetic
chemicals (Shen, 2015). Moreover, accessing, harvesting,
and growing natural products involves navigating diverse,
and often competing, political, environmental and financial
interests, potentially making naturally-derived products
practically and financially unviable [see Goodman and Walsh’s
(2001) overview of the political landscape surrounding
Taxol]. As such, natural products drug discovery largely
fell out of fashion as pharmaceutical companies favored
the use of synthetic compounds in drug manufacturing.
Antibiotic development is also faced with significant
difficulties associated with passing drug trial hurdles and
the perceived and genuine lack of profitability inherent in
short-term treatments.
More recently, however, in the context of the AMR crisis,
natural products have begun to (re)take center stage as companies
explore new avenues for potential antimicrobial drug candidates
(Cragg and Newman, 2013). In this context, the natural
world has been described as an “endless frontier” (Li and
Vederas, 2009) and an “inexhaustible” (Davies, 2011, p. 5)
source of potential candidates for new antimicrobial therapies
(see Brown and Wright, 2016). Coupled with advances in
microbial genomics, bioinformatics, and synthetic biology (see
Thomford et al., 2018), it has been suggested that drug discovery
is undergoing a “renaissance. . . inspired by natural products”
(Harvey, 2007, p. 480) where “we are surely entering a new
golden age of natural products drug discovery” (Shen, 2015,
p. 1297).
The therapeutic use of natural products is, of course, not
limited to pharmaceutical medicines. Natural healing products
on general sale such as Aloe Vera, Manuka honey and
Echinacea have been used as antimicrobial treatments for
centuries and are growing in popularity in the west. Sociologists
have theorized this increased use of natural products (mostly
subsumed under the umbrella of “complementary and alternative
medicines”) as a result of their commercialization (Collyer,
2004), increased skepticism toward biomedicine, dissatisfaction
with traditional doctor/patient relationships and a proliferation
of discourses of holism in health [see Gale (2014) for an
overview]. For Carter et al. (2016), the increased use of these
natural products and, in many cases, their adoption as potential
antimicrobial drug candidates by pharmaceutical companies,
repositions them from alternative, marginal therapies into
the mainstream.
The Case of Clay
One such example is clay (or more specifically minerals
found naturally in clay), whose antimicrobial properties are
well-documented (e.g., Williams, 2019) and which has been
used in various therapeutic forms since the earliest human
civilizations (Hosseinkhani et al., 2017). While therapeutic clay
use has a long history, the contemporary biomedical story
of antimicrobial clay minerals begins in 2002 when French
humanitarian worker Line Brunet de Courssou approached the
World Health Organization with a series of case studies in
which she had used clay, specifically French green clay, to
treat Buruli ulcer (a necrotising soft tissue disease caused by
Mycobacterium ulcerans and where treatment involves combined
antibiotic therapy and often surgery, including amputation)
in Côte d’Ivoire (Williams and Haydel, 2010). In her report,
Brunet de Courssou suggested that clay may provide an effective
way to treat bacterial skin infections commonly found in
Africa and requested financial support to further research
the area. Her application for funding was unsuccessful but
nonetheless prompted scientists in North America to pursue
the antimicrobial potential of clay and its mode of action.
Williams and Haydel (2010, p. 746), for example, state that
Brunet de Courssou’s findings “were the stimuli for our research
into the healing mechanism of clays” and, in the same paper,
thank Brunt de Courssou for bringing antibacterial clays to
their attention.
In the years following Brunet de Courssou’s report, western
researchers began to analyse the mineralogical properties of
the clays used in her work and to ask, more generally, “what
makes. . . clay antibacterial?” (Williams et al., 2011). In other
words, while the healing properties of clay have been known
around the world for thousands of years, researchers began to
investigate the biochemical and mineralogical basis for their
therapeutic benefits. In more recent years, as AMR has loomed
larger as a global health threat, the antimicrobial potential of
clay minerals has been centralized as part of the so-called “new
golden age of natural products drug discovery” (Shen, 2015, p.
1,297) and the antimicrobial properties of clay are beginning
to gain traction in drug discovery science (e.g., Morrison et al.,
2016). Within this, clay-based topical therapies have been shown
to be effective in treating skin conditions, including necrotising
fasciitis, as noted above (Williams et al., 2004), open wounds
(Sirousazar et al., 2011), and acne (Toombs, 2005). Detailed
analysis of clays and their impact on bacterial survival has
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led to the suggestion that the aluminum and iron content of
clays is the toxic component (i.e., what kills bacteria), probably
as a result of localized release of reactive oxygen species at
the bacterial surface (Morrison et al., 2016; Wang et al., 2017;
Zarate-Reyes et al., 2018). The antibacterial action of clays has
been further evidenced in other studies. Considerable work
has been undertaken to characterize the chemical and physical
properties of clays responsible for antibacterial activity (Williams,
2017, 2019). The efficacy of clay against pathogenic bacterial
biofilms has also been confirmed (Caflisch et al., 2018) and
antibacterial clays have been found to reduce drug-resistant
Staphylococcus aureus infection and inflammation in wound
infections in mice (Otto et al., 2016). As such, there is a
clear, and continually emerging, body of scientific evidence
that clay is an effective antimicrobial, and Williams (2019, p.
7) suggests that in the context of a growing antimicrobial
crisis “mimicking the antibacterial mechanisms exhibited by
natural clays could be advantageous in the development of new
antimicrobial agents.”
While the story of clay, and other natural antimicrobials,
in contemporary drug discovery is interesting in itself, in
this article we are concerned with how sociologists might
make sense of this shift in drug discovery science and
theoretically locate natural antimicrobials within the wider AMR
landscape. To begin to address this, for the remainder of this
paper we highlight clay as an example of the (re)entrance
of natural materials into AMR research and drug discovery.
Through this example, we show that the reinvigoration of
natural products drug discovery requires a collaborative,
interdisciplinary approach which locates the social and material
life of natural antimicrobial products alongside their biochemical
and antimicrobial potential. Such an interdisciplinary approach
not only makes visible the uses of these products across
cultural contexts but also, by centralizing the materiality of
natural antimicrobials, has potential impacts for optimizing
antimicrobial use.
To do this, we suggest theoretical “ways in” through which
sociologists might explore the material life of clay and map
these onto its mobility. Here we mean both the physical
movement of clay (from the global south to the global north,
from poor countries to rich ones, from black to white bodies,
and from natural contexts to research laboratories) and its
symbolic mobility from the margins of western medicine into
the mainstream. We do not intend to provide a comprehensive
or instructional account of how to explore medicinal clay and
other antimicrobials. There are undoubtedly other theoretical
framings left unexplored here which could be effectively
mobilized to theorize the use of clay, and other natural
products, in antimicrobial research. Rather, the “ways in” we
propose are intended as heuristic devices to stimulate a novel
sociological discussion of, and focus upon, the materiality of
antimicrobial artifacts. While we focus on the case of clay
specifically, the approaches we outline below are applicable to
other materials emerging from natural products antimicrobial
discovery and, throughout, we provide examples of this
wider applicability.
SOCIOLOGICAL “WAYS IN” TO
ANTIMICROBIAL CLAY
Existing Social Science Research on Clay:
Geophagy
Unsurprisingly, clay has not been prominent on the radar
of medical sociologists. That is not to say, however, that
clay has wholly escaped the attention of social scientists;
anthropologists and geographers have had a sustained interest
in clay’s medicinal uses, particularly the practice of geophagy,
which is the deliberate eating of soil, earth, or clay. Ingestion
of clay has a number of proposed benefits, notably through
its mineral content serving as a nutritional supplement and its
absorptive properties in detoxification and lining the gut to settle
gastrointestinal infections (potentially also as an antimicrobial),
and is common across the global south and east (Henry
and Cring, 2013, p. 181). The practice of geophagy, broadly
speaking, has been conceptualized in one of two ways (see
Henry and Matthews Kwong, 2003). It is either (i) pathologized
as a form of “pica,” that is “compulsive eating of non-food
substances” (Walker et al., 1997, p. 280), or (ii) understood
as a routine part of everyday nutritional life and foodways
(Loveland et al., 1989). While medicine (particularly psychiatry
and public health) has focused on the neurological causes
of geophagy, its negative health consequences and possible
treatments, social scientists have foregrounded geophagy’s
cultural-locatedness and ordinariness in many cultures and
communities globally.
Central to this tension, following Douglas (1966), is the
distinction between “food” and “non-food” (Gonzalez Turmo,
2009) and the positioning of soil within it. In the contemporary
west, soil is understood as “a polluting non-food” which is
“too natural to be acceptable” (Henry and Matthews Kwong,
2003, p. 361–2). Consuming soil in this context is, therefore,
highly stigmatized (Forsyth and Benoit, 1989) and associated
with groups already viewed with a degree of “otherness” such as
women (Allport, 2002), children (Young, 2011) and poor, rural,
black populations of the Southern US states (Frate, 1984).
Conversely, social science approaches to geophagy have
highlighted clay’s legitimacy as a foodstuff and a routine part of
health and nutritional practices in, among other places, Nigeria
(Vermeer, 1966), Ghana (Vermeer, 1971; Hunter, 1973), Kenya
(Geissler et al., 1997), and the Southern USA (Hertz, 1947; Frate,
1984; Forsyth and Benoit, 1989). For Henry and Cring (2013,
p. 181), geophagy’s embeddedness within the ebbs and flows of
everyday life brings with it knowledges and practices, particularly
around selecting and preparing clay, which “bring it into culture.”
In other words, skilled knowledge of choosing which clays are
edible and how to prepare them correctly for consumption brings
geophagy out from hidden sub-cultural corners and into the
mainstream. In his colonial explorations of South America, Von
Humboldt (1872, p. 495) noted that people do not “eat every kind
of clay indifferently” but, rather, select specific types of clay for
eating based on smell, taste and texture (Geissler et al., 1997)
or location (Hertz, 1947). In the Southern USA, Frate (1984, p.
35) compared the selection of edible soil to the selection of wine,
Frontiers in Sociology | www.frontiersin.org 4 April 2020 | Volume 5 | Article 26
Jamie and Sharples Social Material Life Clay
with both gaining “a reputation over the years” and becoming
known for their provenance (also Forsyth and Benoit, 1989,
p. 66).
Across both medical and social science approaches to
geophagy, pregnant women occupy a particularly prominent
position as wider pica behaviors are associated with pregnancy
cravings. Reported rates of geophagy among pregnant women
vary considerably from 0.2% in Denmark (Mikkelsen et al., 2006)
to 92.5% in Nigeria (Izugbara, 2003). Medical approaches to
geophagy in pregnancy focus on the risks of helminth infection,
lead poisoning, dental injury, and gastrointestinal complications
(Ezzeddin et al., 2015). Thus, the predominant medical discourse
has constructed geophagy and pica in pregnancy as a “dangerous
form of self-injurious behavior” (Williams and McAdam, 2012,
p. 2050) and focused on prevention, particularly through
educational programmes for women in the global south.
Conversely, social scientists have pointed out that geophagy
in pregnancy in non-western settings is tied up with wider
cultural practices, beliefs, and “symbolic links between people,
fertility, good health, and ancestral blessings” (Njiru et al.,
2011, p. 455). Geissler et al. (1998) and Izugbara (2003) also
highlight the sacredness of pregnancy-related geophagy and
its associations with fertility deities and the perceived life-
giving forces of the earth. As such, as a highly gendered
practice where history, place, culture, family, gods, and female
bodies meet, the medical approach of simply educating
pregnant women against geophagy becomes complex (Corbett
et al., 2003). Researchers have demonstrated that treating
indigenous people, places, and cultures as tabula rasa onto
which western biomedical messages can be inscribed ignores
existing cultural practices, and can lead to significant, and
potentially harmful, distortions of public health messages
(e.g., Williams-Blangero et al., 1998).
Clay has, then, enjoyed some prominence in social science
literature albeit amalgamated with other types of soil and
earth and examined almost wholly through the lens of
geophagy by anthropologists and geographers. There is
limited research on what clay-based practices are currently
occurring globally as wider medicinal uses of clay only
occasionally appear in geophagy research (e.g., Izugbara, 2003,
p. 194) and anthropological research on geophagy has slowed
considerably since a flurry of activity in the 1970s. While
geophagy research provides a useful context and establishes the
widespread use of clay as a medicinal antimicrobial artifact,
this article advocates a broader sociological investigation
into clay as it moves into mainstream biomedical research
as part of a focus on natural products antimicrobial drug
discovery. As clay and other natural antimicrobials increasingly
take center stage in antimicrobial drug research, credible
theoretical lenses to their social, and material lives will be
vital for ensuring sociologists are included in the policy,
practice, and research conversation. We now turn to propose
three theoretical “ways in” to understanding clay as an
antimicrobial agent which we map onto the physical and
symbolic mobility of clay into, within, and out of western
biomedical laboratories.
Way in 1: Clay in Context: Post-colonial
Approaches
A post-colonial lens is perhaps the most logical entry
point into a sociological analysis of medicinal clay as
it provides a way to theorize clay, and its use, in its de-
westernized context prior to its movement and adoption into
western biomedicine.
In short, post-colonialism, as a set of intersecting theoretical
approaches, is concerned with the legacies of colonial ideologies
and power and the ways in which contemporary global
economics, politics and culture are rooted in colonial projects.
Said’s (1978) seminal text Orientalism is pertinent here. In it,
he outlines the ways that western powers, through centuries of
colonial rule, came to define indigenous people and practices in
the global south and east [what Hall (1996) calls the “non-west”]
as oriental “other,” engaging in and driven by “savage,” strange
and “primitive” beliefs and practices.
Post-colonial theories have usefully been applied to
understand the history of medicine (see Anderson, 1998)
and science (see Seth, 2009) where researchers have, among
other foci, drawn attention to colonialism’s consistent devaluing
of traditional practices and knowledge in favor of a model where
western medicine and science were understood as “gifts” to
colonies (Seth, 2009, p. 373). Philosopher Lévy-Bruhl’s work
on “the primitive” is a striking example of the naturalization of
European medical and scientific superiority which post-colonial
scholars seek to untangle. In it, Lévy-Bruhl consistently utilizes
anecdotes of behavior from diverse contexts to reproduce a
distinction between “primitives” and the “civilized” world,
confirming the superiority of Europe and entrenching the
notion that colonized nations “are simply different from us” [see
Bernasconi (2005), p. 231–22 for an overview].
Similar devaluing of indigenous cultures is echoed elsewhere
in relation to medical practice specifically. In her overview of
British colonial perceptions of Indian and Burmese medicine,
Edwards (2010, p. 28) notes that in the late nineteenth
century, traditional Indianmedicine was dismissed as “despicable
quackery” despite some “western” practices, such as inoculation
against smallpox, having been practiced for centuries before the
British arrived. In Zimbabwe, this valorization of traditional
medicine went further where, under the Witchcraft Suppression
Act (1899), the majority of traditional medical healers, practices,
materials, medicines and objects were criminalized for being
non-scientific and dangerous (Mawere, 2014).
By centralizing and problematizing this process of devaluing
traditional medical practices, post-colonial approaches offer
a useful lens for understanding the ways medicinal clay is
positioned within modern, western medical practice. This can
clearly be seen in the case of geophagy where colonial gazes
“are still active today” in framing this practice as a form of
pica (Henry and Cring, 2013, p. 186). Beyond this, however,
post-colonialism can help us question some of the fundamental
constructs underpinning the story of medicinal clay’s emergence
into western biomedicine, most notably claims about its newness
and the infrastructure through which it physically moves to
the west.
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First, as we have mentioned above, the use of clay
for antimicrobial purposes is not novel; clay has had a
sustained prominence throughout medical history. While most
contemporary biomedical papers on clay outline this longer
history as context for a biomedical framing, this in itself
is part of the problem—medicinal clay use is constructed,
through this narrative, as an historical artifact, and a set of
knowledges circulating around the great ancient civilizations,
rather than a practice which is still continuing in formerly
colonized spaces. Williams’ (2019) recent overview of clay’s
historic and continued use globally, for example, opens
with accounts of clay use by the earliest humans and its
importance in ancient Greek and Roman medicine while
devoting almost no space to the current use of clay in the
global south.
This kind of positioning of natural antimicrobials invisibilizes
medical knowledge and practice from contexts where
natural products form the basis of much traditional and
contemporary medical practice. In the case of plants, the
World Health Organization (2005) suggests that 80% of the
world’s population uses traditional, plant-derived medicine
as primary health care. Moreover, in a report on the State
of the World’s Plants, Willis (2017, p. 22) notes that at least
28,187 species are recorded as being of medicinal use, mostly
in rural areas of the global south where traditional medicine
is accessible and affordable, and often trusted more than
western pharmaceuticals.
Despite this, the contemporary relevance of medicinal clay is
located almost wholly within the frame of contemporary, western
medicine. The “story” of clay’s emergence intomedicine (much as
we have told it above) starts at the point of its mobility into the
western biomedical gaze through Brunet de Courssou’s work and
constructs a future which is entangled with western biomedical
agendas (AMR, safety concerns), technologies (screening,
analytics), and practices (patenting, commercializing). Taking a
post-colonial approach helps to elaborate on the de-westernized
story of medicinal clay, locating it within non-western knowledge
assemblages, markets and traditions.
Post-colonial approaches can also help us attend to the
implications of clay’s physical mobility as it moves from
its natural (potentially sacred) contexts in the global south
into western biomedical research spaces. Here, the notion of
“bioprospecting” becomes useful. For Hayden (2003, p. 1) this
refers to “corporate drug development based on medicinal
plants, traditional knowledge and microbes culled from the
‘biodiversity-rich’ regions of the globe.” Schiebinger (2004) has
related the modern practice of bioprospecting to the actions of
early European colonialists who exploited plant sources in the
global south in the name of botany and medical science. While
contemporary bioprospecting legislation requires corporations
to remunerate indigenous populations for the exploitation of
their land and resources, this model nonetheless naturalizes
the trade of goods from south to north, poor to rich, and
prioritizes western scientific and corporate development. Most
of the existing work on bioprospecting looks specifically at the
case of plants but, as clay begins to gain traction as a biomedical
substance, this scope could be broadened to interrogate where
the clay in western biomedical laboratories has come from, and
through what means it arrived.
Way in 2: Movement Around and Out of
Science: Revisiting Laboratory Life
Once clay has, then, moved from the global south into the
western biomedical gaze, it is subject to scientific work where
the evidence of its antimicrobial potential is established. Given
this, our next “way in” to understanding antimicrobials derived
from natural products is slightly different in proposing both
a theoretical and methodological approach. In particular, we
suggest a return to “laboratory life” to capture the ways that
“the daily activities of working scientists lead to the construction
of scientific facts” (Latour and Woolgar, 1979, p. 40). We use
the phrase “return to” deliberately because, as Doing (2008)
points out, following a flurry of publications during the 1970s
and 1980s, few laboratory studies have actually emerged out
of STS scholarship, despite their foundational impact on the
field. Given this, Doing (2008, p. 281) goes further and calls
for “a reengagement between ethnographic work in laboratories
and the now established field of STS.” We suggest that the
(re)emerging field of natural product drug discovery would
provide an excellent site for such a reengagement and would
illuminate the ways in which the antimicrobial potential of clay
is brought into being.
Briefly, classical laboratory studies were concerned with
how scientific facts are produced interactionally, through
everyday scientific experimentation, discussion, technologies
and negotiation. As Knorr Cetina (1995, p. 141) argues, the
mission of these studies was to show the “process of knowledge
production as ‘constructive’ rather than descriptive.” Such a focus
represented a shift from demarcationist philosophy such as that
of Karl Popper who argued that a distinct demarcation between
science and non-science could exist. In contrast, laboratory
studies were, and still are, concerned with the production
of scientific knowledge in situ and uncovering the messiness
of scientific practice which is invisibilized in publications
where scientific facts and methods are presented as fixed and
logical (Knorr Cetina, 1981). More recently, in his research
on pharmaceutical company chemical laboratories, Barry (2005)
shows that molecules are not “discovered” but, rather, “invented”
as “informed materials” through laboratory work wherein the
material structure becomes richer and better-known through
the compilation of information and data. This is echoed by
Hardon and Sanabria (2017, p. 118) who suggest that “there is
no pure (pharmaceutical) object that precedes its socialization
and interpretation.” Laboratory studies are, then, concerned with
uncovering the processes of this socialization and interpretation.
While research in this tradition primarily focused on
the microsocial action of everyday work within specific
laboratories, Fujimura (1987) usefully demonstrated the
constraints and influences on scientific work from “outside”
of individual laboratories, such as from regulators, sponsors
and industries. In this sense, the construction of scientific
facts is not just contingent upon everyday work in the
laboratory but an alignment of local (the necessary
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laboratory tasks are doable), institutional (these tasks are
feasible within a given laboratory space), and wider field
(the research is viewed as worthwhile by the broader
scientific community) concerns and constraints (Fujimura,
1987).
Given we are advocating a directional shift toward the
materiality of natural antimicrobials, the laboratories in which
this materiality is produced is a logical research site for
sociologists. Such a focus would illuminate the ways in which
clay materials are inscribed with antimicrobial potential and how
this potential is represented to the wider scientific community
through publications (see Latour and Woolgar, 1979). In the
case of clay, scientists use microbiological and biochemical
techniques to probe the susceptibility of microorganisms (e.g.,
minimum inhibitory concentrations, viability assays) and define
the mechanism of action (e.g., structural and elemental analysis
of the clays themselves coupled with molecular effects on
microbial constituents, such as lipids, proteins and nucleic acids)
(see Williams, 2019). These methodologies and technologies act
as an “inscription device” to “transform [the] material substance
into a figure or diagram” (Latour and Woolgar, 1979, p. 51),
which is then used to tell the story of the antimicrobial action
of a particular clay. A sociological investigation into the inner
workings of this process would be valuable but so too would
an analysis of the entanglements of actors, both human (e.g.,
scientists, marketers, funding panels) and non-human (e.g.,
technologies, images, research agendas). For example, Goodman
and Walsh (2001) highlight the case of Taxol obtained from the
Pacific yew tree, whereby disharmony in natural antimicrobial
science was not limited to members of a particular scientific
group but extended to politicians, funders, associated industrial
stakeholders (lumber or mining companies) and indigenous
populations. This final point, of course, circles back to post-
colonial approaches.
A focus on the laboratory life of natural antimicrobials would
also usefully go beyond the physical limits of the laboratory
to follow clay on its physical and symbolic journey to its
scientific facthood in other spaces. In other words, we might
usefully ask how is the “fact” of clay’s antimicrobial potential
constructed, and what happens to this “fact” once it is black-
boxed and leaves the laboratory through scientific papers as
“evidence.” This focus particularly calls to mind other STS work
around the role of hope, promises and expectations. Much
of this work is centered on the future-oriented discourses to
emerge from the Human Genome Project and its resultant
technologies (e.g., Hedgecoe and Martin, 2003). This approach
recognizes the social and political life of scientific expectations,
acknowledging that these promises shape research agendas and
can hold significant power in mobilizing resources at micro,
meso and macro levels of science work (Borup et al., 2006). In
the case of natural antimicrobials, scientific papers are awash
with expectations of their revolutionary potential. In some cases,
these promissory discourses have also crossed the rubicon into
media reporting which is predictably filled with sensationalized
accounts of natural antimicrobials’ potential. For example,
the Daily Mail (Andrews, 2018) reports the antimicrobial
action of Atlantic sponges as “revolutionary,” while Independent
journalist Rodgers (2007) asks whether clay might be the “new
Penicillin.” Research is needed to understand what purpose
these promises serve. In particular because as the (re)emergence
of natural antimicrobial drug discovery is in its infancy
and global attention is increasingly turned toward innovative
approaches to AMR, the political potential of these promises is
worth unpacking.
Way in 3: Moving From the Margins to the
Mainstream: Developing Clay’s Value
As clay physically moves from the global south into western
biomedical research spaces and out again as a black-boxed
antimicrobial fact, it also shifts symbolically from inert “non-
stuff” into an artifact with potential value.
Here we are not talking only about commercial worth but
rather value as an entanglement of social, cultural, scientific,
medical, and economic value. What we are specifically referring
to is clay’s movement from the margins of biomedicine
(associated with “alternative” medical practices of the non-west)
into the mainstream (as a credible biomedical antimicrobial) and
the concomitant social legitimization and economic valuation
of clay as an artifact or material. In other words, using
Saks (1995) power model, as clay moves toward the power
structures of science, medicine and healthcare, it attains value
and legitimacy and its placement within the category “alternative”
becomes ambiguous.
This movement of clay from the margins to the mainstream
is partly driven by the changing evidence base around
its antimicrobial potential. As clay moves into the western
biomedical gaze, evidence about its antimicrobial functionality is
increasingly obtained from standardized research practices which
are understood as more legitimate than “anecdotal” observations
or case studies from the past or from the global south (see
Timmermans and Berg, 2003). A sociological exploration of clay
would do well to interrogate this evidential shift to analyse the
ways that clay’s antimicrobial “facthood” comes into being and
becomes reified.
Here too the notion of valuation practices can help create a
more holistic approach which incorporates, by moving beyond,
economics, and evidence. Dussauge et al.’s (2015) recently
developed notion of “valuographies” may be helpfully employed
to understand the potential antimicrobial value attributed to clay
as it moves into the western biomedical gaze. In the concluding
chapter of their anthology on value practices, Dussauge et al.
(2015, p. 266) call for more research exploring “values in-the-
making” in medicine and the life sciences to “examine how
certain things come to be considered valuable and desirable” and
what the implications are of increased desirability. In one of
the anthology’s chapters, Löwy (2015), for example, highlights
how the increased valuation of prenatal screening for Down
Syndrome (by both clinicians and parents) repositioned the test
from a niche procedure in high risk cases to a mainstream tool
enmeshed in discourses of eugenics. In other words, as the non-
essential desirability of prenatal screening increased, it shifted out
of specialist obstetric practice and into mainstream pregnancy
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care carrying with it financial implications for service providers,
and increased surveillance of pregnant bodies.
Central to Dussauge et al.’s (2015, p. 7) work is an ambition
is to move away from a construction of value wholly “revolving
around capital and labor” to one in which multiple value forms
are commensurable and are dynamically created and recreated
in practice. A complementary reading of Garcia-Parpet’s (2007)
work on the construction of “perfect” markets is useful here to
shed light on the social construction of new economic markets.
Through a focus on a strawberry auction in Fontaines-de-
Sologne, Garcia-Parpet demonstrates that the development of
“perfect” markets (see pages 25–26 for an overview) is not solely
reliant on financial equilibrium massaged by “invisible hands” of
self-interest but is in a constant state of (re)creation through the
development of networks, vigilance, and the social identities of
the actors involved. In other words, Garcia-Parpet (2007, p. 20)
shows that “social factors. . . [intervene] all across the practical
processes of making up this, the purest of ‘economic’ markets.”
Such entanglements of actors, technologies, products and
finances (as captured by the valuographies model) are important
for understanding the ways in which natural antimicrobials
attain both social and economic value; in other words, how
they come to be both desirable (i.e., legitimized) and profitable
(i.e., have markets created around them). We might, for
example, ask how clay is positioned within a scientific research
landscape where fundamental research is increasingly eclipsed
by research guided by industrial agendas, which are necessarily
profit-driven (Quaglione et al., 2014). How, as clay gains
mainstream biomedical value, do research questions change from
fundamental explorations of how clay works (e.g., Williams
et al., 2011) to questions of application, commercialization
and increased efficiency of clay-based medical products and
practices? Furthermore, how might a “perfect market” as
exemplified in Garcia-Parpet’s work, develop around clay?
However, clay’s increased social and economic value does not
just lie in its potential scientific and medical applications, but
also in its marketability as a beauty and cosmetic artifact. In
recent years, clay has made a rather startling appearance onto
the western beauty scene with promises to do things like “clean,”
“detoxify” and “renew” in a “natural” and environmentally-
conscious way. This entrance of clay into the western beauty
landscape has yet to be theorized but the increased value of
clay in this space chimes with several existing social science
research concerns such as the movement toward ecologically-
sound capitalism, the increased appetite for “natural” lifestyles
(Edmonds, 2008), and the desire to engage in non-western
practices which are seen as “authentic” (Campbell, 2008).
This increased presence of clay in beauty and cosmetic
products raises questions about the discourses of “detoxification”
and “cleansing” which underpin clay-based beauty products,
particularly with respect to what they accomplish and to whom
they are addressed. Theoretically, one might put Douglas (1966)
to work here to understand the construction of bodily pollutants
and read this alongside feminist work which highlights the
inscription of gender norms (in this case to be clean, pure, and
detoxified) onto female bodies (e.g., Wolf, 1991). This would
help us to appreciate, again employing Dussauge et al. (2015)
work, how a commercial market (this one focused on beauty and
cosmetics) around clay is developing.
EXPLORING THE RELEVANCE OF
MATERIALITY FOR ANTIBIOTIC
ADHERENCE AND OPTIMIZATION
While research through any, and all, of these “ways in” would
be intellectually meaningful, this novel focus on materiality
goes beyond theoretical talking points and has implications for
optimizing antimicrobial use. Most adherence research to date
has been preoccupied with identifying patterns of medicines use
based on demographic factors such as age, sex, socio-economic
status and ethnicity. These models, however, fail to address
how, within complex social worlds, medicines-use decisions are
actually formulated, and the nuanced reasons why patients may
utilize medicines sub-optimally (Rathbone et al., 2017).
Within social sciences, progress has been made on remedying
this rather one-dimensional approach by placing patients’
beliefs and wider lifeworlds at the core of analysis, positioning
medicines as “socially embedded phenomena” where decisions
about use are made within a complex web of relationships,
spaces, roles and identities (Cohen et al., 2001). Conrad
(1985) calls this “medication practice” and highlights the ways
suboptimal medicines use can be a form of control for patients.
Others highlight the importance of place and space in patient
relationships with medicines (Hodgetts et al., 2011; Dew et al.,
2014) and the mobility of clinical categories between spaces
Webster, Douglas and Lewis (2009).
Anthropologists have made the most significant leaps in
mapping the “social lives of medicines,” highlighting that
medicines are more than just chemical things and, instead, take
on social, economic, and political meanings which can affect the
ways they are used (Whyte et al., 2002). In their comprehensive
review of recent work in the anthropology of pharmaceuticals,
Hardon and Sanabria (2017, p. 118) convincingly outline
the ways that “drugs are rendered efficacious in laboratories,
therapeutic settings, drug outlets, and everyday lives across
regulatory settings.” Refreshing, and relevant here, is that their
paper aims to “examine what lies beneath the pharmaceutical
object’s surface, unpacking the thing” (ibid). Through an
overview of the construction of medicines at five key sites in
their lifecycle (trials, regulatory frameworks, marketing, care
practices, and in individual bodies), they demonstrate that
the use of medicines is relational and intertwined with their
diverse inscriptions, and part of an on-going, constantly evolving
interaction between the identities of patients and medicines
themselves (Rathbone et al., 2017).
Despite this, their review falls somewhat short of its promise
to burrow beneath the surface of medicines and open up the
“thing” (Appadurai, 1986). Inasmuch, they commence their
narrative with randomized controlled trials (RCTs), overlooking
the underpinning scientific studies during which the material
life of the medicinal thing is of central importance. Hardon
and Sanabria’s (2017) paper is an exemplar of a wider
approach wherein medicines themselves (particularly their active
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ingredients) are essentialised and positioned as black-boxed
objects around which practices, values, beliefs, behaviors and
identities circulate. In other words, while the focus on social and
cultural lives of medicines is important, there is limited attention
given to what medicines themselves actually are—what is the
thing that patients are not adhering to or taking optimally?
While anthropologists have credibly highlighted that
medicines are not just chemical objects, their “chemical lives”
should nonetheless feature in a holistic analysis of medicines
themselves as they are often implicated in how they are used and
adhered to. Formulation science has repeatedly demonstrated
that the physical properties of medicines (their size, shape, taste,
smell, mode of delivery) are important for how medicines are
perceived and used by patients. In their review of formulation
challenges for pediatric practice, for example, Nunn and
Williams (2005) note the importance of masking the naturally
bitter taste of medicines to encourage adherence in children.
Similarly, through experimental research, Wan et al. (2015)
reveal how the shape and color of tablets significantly affects
patients’ perceptions of their ease of use and effectiveness, which
in turn impacts adherence.
Beyond this, others have highlighted that medicines’
ingredients are vital for patients’ decisions about their use. This
is perhaps most obvious in the case of dietary preferences, and
religious and cultural beliefs. In their research on the impact
of religious beliefs in medicines use, Eriksson et al. (2013)
found that Muslims, Hindus, and Sikhs refused medicinal
devices containing porcine and/or bovine derivatives in all
but emergency circumstances. While Enoch et al. (2005)
suggest that healthcare practitioners should inform patients
about medicinal ingredients, they also found that none of the
practitioners surveyed knew the correct ingredients of the
medicines prescribed, potentially leading patients to their own
research and harmful “tinkering” with their prescribed regimes
(to quote Mol, 2008). Sattar et al. (2004) outline four case studies
in which patients, upon discovering their medicines contained
products prohibited by their religion, immediately stopped
treatment, leading to relapses in condition.
In the context of the (re)emergence of natural products drug
discovery, the active ingredients in new antibiotics may well
be products which have historically sat outside of conventional
biomedical models (notably here, clay). Opening up the black
box of medicines and their chemical and material lives will
enable us to grasp how diverse active ingredients are perceived
and influence use. For example, will patients accept clay-
based poultices as a legitimate medicine for treating wound
infections? How will their perceptions affect their use of
poultices? How can prescribers best counsel patients to ensure
optimal use of innovative novel medicines? These are important
questions for scientific researchers, practitioners and policy-
makers in AMR, and ones which sociology is well-placed
to answer.
DISCUSSION
In this paper, we have suggested a new direction for sociological
research on AMR that examines the social and material life
of antimicrobials themselves. Such a focus is pertinent at
a time when diverse materials, particularly natural products,
are being explored for their potential as new antimicrobial
drug candidates. We selected clay as an appropriate example
since its antimicrobial potential is well-documented (Williams,
2019) and it has a thriving research community to which
sociology has much to offer but has not yet engaged with.
For instance, sociology is conspicuously absent from Henry
and Matthews Kwong’s (2003, p. 354–355) observations on the
diversity of disciplinary perspectives on geophagy: “research
is conducted by a striking variety of specialists in the fields
of primatology, biology, chemistry, mineralogy, parasitology,
medicine, nutrition, anthropology, geography and public health.”
Henry and Cring (2013) similarly note that interdisciplinarity
is vital for deeper research into the social life of clay. More
broadly, sociologists have advocated the need to include our
research, approaches, theories and methodologies in AMR
research. For Lorencatto et al. (2018), sociologists have a key role
to play in supporting prescribing behavior change interventions
while Will (2018) argues that more nuanced theorizing around
AMR will support sociology to become part of the policy and
practice solution.
Taking the illustration of antibacterial clay, we have suggested
a number of approaches for sociologists to begin exploring
the social and material life of natural antimicrobials. We have
mapped these theoretical lenses onto the physical and symbolic
mobility of clay into, within, and out of western biomedical
laboratories. This is not an exhaustive list of theoretical “ways in”
to explore the (re)emergence of natural products in antimicrobial
research; there are certainly additional lenses which would
be valuable to employ in tandem that we have not touched
upon here. Our goal was not to compile a comprehensive
account, but to present what we see as fruitful “ways in” as
heuristic devices to stimulate discussion within our discipline,
and beyond, as to how we might credibly tackle this new
direction in AMR research. Moreover, the “ways in” that we have
proposed here also have currency for exploring other natural
product-based medicines more broadly (i.e., not limited to
antimicrobials). The “ways in” we have presented are deliberately
disparate to both draw out the diversity of issues enmeshed
in questions of natural antimicrobials, and to demonstrate
that sociology has the broad theoretical arsenal to approach
these. We are not suggesting that any given future research
on natural antimicrobials should attempt to synthesize and
incorporate all of these theoretical frameworks but, rather, bring
specific frameworks in and out of prominence in addressing
particular aspects of natural antimicrobial materiality. We are,
then, suggesting these frameworks as “ways in” for sociologists
to begin thinking about a materiality approach to antimicrobial
products, rather than providing an instructional schema.
Nonetheless, there are several thematic coalescences and
points of confluence in the disparate concepts and frameworks
outlined above. Most notably, taken together in much the
same way we have presented them here, these frameworks
and foci provide a holistic theoretical reading of the “story”
of natural antimicrobials’ movement into and around western
biomedicine. In other words, a single aspect of clay’s (and other
natural antimicrobials’) entrance into the western biomedical
gaze should not be fully understood in isolation but, rather,
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should give space to the tangential issues. For example, an
examination primarily focused on the development of new
markets around clay products (both medical and cosmetic, from
a valuographies perspective) ought to nod to the development
of evidence underpinning this market (from an STS perspective)
which is, in turn, informed by clay’s longer history as a therapy
(from a post-colonial perspective).
These diverse theoretical frameworks are all, at various times
and to varying degrees, underpinned by notions of space,
legitimacy, and practice, where the legitimacy of clay shifts (from
“alternative” tomainstream) as it moves into diverse spaces (from
global south to north) and is practiced upon in diverse ways
(through scientific experimentation). For example, post-colonial
approaches can help us to illuminate the ways “traditional”
uses of clay in the global south are positioned as illegitimate
through “colonial gazes” (Henry and Cring, 2013: 186) and STS
frameworks can show us how legitimacy of clay is achieved
through scientific experimentation. Outside of the laboratory,
legitimacy of a medicine or a drug regime is central to its use by
patients (Cohen et al., 2001).
This new route in AMR research requires a considerable
degree of interdisciplinarity. While we have argued here in
favor of a sociological focus on the social and material lives
of natural antimicrobials, we are not advocating a partisan
approach where sociologists focus exclusively on the analytical
frameworks offered by others in our discipline. Indeed, as
we have shown, discipline-hopping frameworks such as STS
and post-colonial studies need to be at the heart of this
new direction. We contend, moreover, that sociologists should
not just collaborate with our close disciplinary neighbors
(namely anthropology, geography, and psychology). Rather,
we ought to develop networks spanning social, biological,
physical, and earth sciences to promote a holistic approach
to social and material life. Many of the questions at the
center of natural antimicrobials (e.g., the nature of the stuff
itself, its movement into biomedicine and its commercial
value) are shared across disciplines and best addressed through
collaborative approaches. Working in pre-existing disciplinary
silos constrains the degree to which the material life of natural
antimicrobials can be fully understood and their practical
and clinical utility fully realized. While laboratory scientists
are keenly focused on identifying the physical, mineralogical,
and chemical nature underpinning clay’s antimicrobial action,
its usefulness as a western biomedicine is an inherently
social and cultural question. These questions concern, among
other issues, whether prescribers are convinced by medicines
with clay as an active ingredient and whether patients
will adhere to clay-based medicines regimes. Similarly, while
sociologists can identify an interesting story in clay’s mobility,
to convincingly take a materiality approach such as we have
advocated above requires a degree of engagement with the
production of physical and chemical materiality through diverse
scientific techniques.
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